CD36 and inflammatory bowel disease: The absorption of dietary VLCFAs is largely mediated by intestinal CD36 [44], and the number of CD36-expressing cells is reduced in the inflamed mucosa of patients with IBD [45], but impaired intestinal uptake of VLCFA will affect the levels of all VLCFAs.